ILMN
ILMN
NASDAQ · Life Sciences Tools & Services

Illumina Inc

$187.96
-5.76 (-2.97%)
As of Aug 8, 1:10 AM ET ·
Analyst Consensus
Buy
28
Analysts
High
Coverage
Buy 17 61%
Hold 8 29%
Sell 3 11%
Price Target
Analyst Price Target -9.9% upside
Low Target $114.37
Average Target $169.36
High Target $229.23
Current Price $187.96
Current
$187.96
Target
$169.36
$114.37 $169.36 avg $229.23
Scenario Analysis
Bear Case
$114.37
-39.2%
Low target
Base Case
$169.36
-9.9%
Avg target
Bull Case
$229.23
+22.0%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$207.00
-9.2% from high
52-Week Low
$88.00
+113.6% from low
50-Day SMA
$136.22
+38.0% vs SMA
200-Day SMA
$108.49
+73.3% vs SMA
RSI (14)
17.5
Oversold
Target vs 52W High
$169.36
-18.2% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 36 81% $369.21 -37.8%
DHR
Danaher Corp
Strong Buy 32 84% $158.11 -22.8%
A
Agilent Technologies Inc
Strong Buy 29 79% $64.69 -55.7%
WAT
Waters Corp
Hold 30 53% $189.60 -53.4%
IQV
Iqvia Holdings Inc
Strong Buy 29 76% $82.96 -65.2%
ILMN
Illumina Inc
Buy 28 61% $169.36 -9.9%
MTD
Mettler-Toledo International
Hold 20 50% $170.43 -88.1%
WST
West Pharmaceutical Services
Strong Buy 22 91% $136.24 -61.5%